Crossref
journal-article
Elsevier BV
Critical Reviews in Oncology/Hematology (78)
References
475
Referenced
77
10.1182/blood.V11.9.781.781
/ Blood / Fibrinolysis in the organism by Astrup (1956){'key': '10.1016/S1040-8428(86)80014-2_bib2', 'first-page': '107', 'article-title': 'Fibrinolysis', 'volume': '7', 'author': 'Fearniey', 'year': '1973', 'journal-title': 'Adv. Drug Res.'}
/ Adv. Drug Res. / Fibrinolysis by Fearniey (1973)10.4049/jimmunol.42.2.109
/ J. Immunol. / Factor in normal blood which participates in streptococcal fibrinolysis by Miistone (1941)10.1084/jem.58.4.485
/ J. Exp. Med. / Fibrinolytic activity of hemolytic streptococci by Tillet (1933)10.3181/00379727-57-14691
/ Proc. Soc. Exp. Biol. Med. / Nature and role of the lytic factor in hemolytic streptococcal fibrinolysis by Kaplan (1944)10.1085/jgp.28.4.363
/ J. Gen. Physiol. / Streptococcal fibrinolysis: proteolytic reaction due to serum enzyme activated by streptococcal fibrinolysis by Christensen (1945)10.1085/jgp.28.6.559
/ J. Gen. Physiol. / Proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors by Christensen (1945)10.1038/159681b0
/ Nature (London) / Fibrinolysis in animal organism by Astrup (1947)10.1038/159779a0
/ Nature (London) / Fibrinolytic activity of normal urine by Macfarlane (1947){'key': '10.1016/S1040-8428(86)80014-2_bib10', 'first-page': '530', 'article-title': 'The fibrinolytic activity of urine', 'volume': '32', 'author': 'Williams', 'year': '1951', 'journal-title': 'Br. J. Exp. Pathol.'}
/ Br. J. Exp. Pathol. / The fibrinolytic activity of urine by Williams (1951)10.3181/00379727-82-20097
/ Proc. Soc. Exp. Biol. Med. / Plasminogen activator in spontaneously active human blood by Müllertz (1953)10.1016/0005-2795(79)90205-8
/ Biochim. Biophys. Acta / Purification and partial characterization of plasminogen activator from human uterine tissue by Rijken (1979)10.1016/0049-3848(80)90204-2
/ Thromb. Res. / Relationship between tissue plasminogen activator and the activators in blood and vascular wall by Rijken (1980){'key': '10.1016/S1040-8428(86)80014-2_bib14', 'first-page': '477', 'article-title': 'Immunological characterization of plasminogen activator activities in human tissues and body fluids', 'volume': '97', 'author': 'Rijken', 'year': '1981', 'journal-title': 'J. Lab. Clin. Med.'}
/ J. Lab. Clin. Med. / Immunological characterization of plasminogen activator activities in human tissues and body fluids by Rijken (1981)10.1016/0304-4165(82)90187-8
/ Biochim. Biophys. Acta. / Purification and characterization of human kidney plasminogen activator dissimilar to urokinase by Sueishi (1982)10.1016/0049-3848(79)90002-1
/ Thromb. Res. / Demonstration of urokinase antigen in blood by Shakespeare (1979)10.1111/j.1365-2141.1982.tb07300.x
/ Br. J. Haematol. / Demonstration of urokinase-related fibrinolytic activity in human plasma by Wijngaards (1982)10.1016/S0021-9258(19)81106-7
/ J. Biol. Chem. / Isolation and characterization of urokinase from human plasma by Wun (1982)10.1016/S0021-9258(17)37840-7
/ J. Biol. Chem. / Immunological characterization of multiple molecular weight forms of human cell plasminogen activators by Vetterlein (1979)10.1016/0006-291X(82)90971-8
/ Biochem. Biophys. Res. Commun. / Two types of plasminogen activators secreted by MCF-7 cells by Shyamala (1982){'key': '10.1016/S1040-8428(86)80014-2_bib21', 'series-title': 'Biological Markers of Neoplasia: Basic and Applied Aspects', 'first-page': '433', 'author': 'Christman', 'year': '1978'}
/ Biological Markers of Neoplasia: Basic and Applied Aspects by Christman (1978)10.1021/bi00565a001
/ Biochemistry / Purification of plasminogen activator from Rous Sarcoma Virus transformed chick embryo fibroblasts treated with the tumor promotor phorbol-12-myristate-13-acetate by Goldfarb (1980)10.1515/bchm2.1982.363.2.1043
/ Hoppe-Seyler's Z. Physiol. Chem. / The complete amino acid sequence of low molecular mass urokinase from human urine by Steffens (1982)10.1016/0014-5793(80)81163-X
/ FEBS Lett. / The glycoprotein nature of human plasminogen activators by McLennan (1980)10.1016/0002-8703(68)90100-2
/ Am. Heart J. / A new approach to the studies of the fibrinolytic enzyme system in man by Cash (1968)10.1016/S0140-6736(66)90766-5
/ Lancet / Fibrinolytic activity related to age in survivors of myocardial infarction by Chakrabarti (1966)10.1111/j.0954-6820.1969.tb01431.x
/ Acta Med. Scand. / Low fibrinolytic activity in the walls of veins of patients with thrombosis by Pandolfi (1969)10.1161/01.RES.32.6.752
/ Circ. Res. / Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease by Rosing (1973)10.1001/archsurg.1974.01360020169033
/ Arch. Surg. / Altered endogenous fibrinolysis and biochemical factors in atherosclerosis by Pesbody (1974)10.1055/s-0038-1649159
/ Thromb. Diath. Haemorrh. / Abnormalities in clotting and thrombolysis as a risk factor for stroke by Pligeram (1974)10.1136/bmj.2.6041.910
/ Br. Med. J. / Preoperative prediction of postoperative deep vein thrombosis by Clayton (1976){'key': '10.1016/S1040-8428(86)80014-2_bib32', 'first-page': '593', 'article-title': 'Role of the contact factor (Hageman factor) in fibrinolysis', 'volume': '3', 'author': 'Neiwiarowski', 'year': '1959', 'journal-title': 'Thromb. Diath. Haemorrh.'}
/ Thromb. Diath. Haemorrh. / Role of the contact factor (Hageman factor) in fibrinolysis by Neiwiarowski (1959)10.1172/JCI106145
/ J. Clin. Invest. / Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors by Ogston (1969){'key': '10.1016/S1040-8428(86)80014-2_bib34', 'first-page': '50', 'article-title': 'New hypothesis for the molecular mechanism of surface-dependent activation of Hageman factor (factor XII)', 'volume': '38', 'author': 'Griffin', 'year': '1977', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / New hypothesis for the molecular mechanism of surface-dependent activation of Hageman factor (factor XII) by Griffin (1977)10.1073/pnas.75.4.1998
/ Proc. Natl. Acad. Sci. U.S.A. / Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII) by Griffin (1978)10.1055/s-0038-1646687
/ Thromb. Haemost. / Molecular mechanisms of fibrinolysis in man by Kaplan (1978)10.1016/0049-3848(78)90003-8
/ Thromb. Res. / C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis by Kluft (1977){'key': '10.1016/S1040-8428(86)80014-2_bib38', 'first-page': '15', 'article-title': 'Single chain form of urokinase in human plasma', 'volume': '14', 'author': 'Hauert', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Single chain form of urokinase in human plasma by Hauert (1984){'key': '10.1016/S1040-8428(86)80014-2_bib39', 'series-title': '16th Int. Congr. Haematol.', 'first-page': '341', 'article-title': 'Acquired anticoagulants against factor XI and XII in patients with severe thrombotic disease', 'author': 'Hedner', 'year': '1976'}
/ 16th Int. Congr. Haematol. / Acquired anticoagulants against factor XI and XII in patients with severe thrombotic disease by Hedner (1976){'key': '10.1016/S1040-8428(86)80014-2_bib40', 'first-page': '351', 'article-title': 'Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator', 'volume': '6', 'author': 'Kluft', 'year': '1977', 'journal-title': 'Haemostasis'}
/ Haemostasis / Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator by Kluft (1977)10.1055/s-0038-1649120
/ Thromb. Diath. Haemorrh. / Studies on an inhibitor of plasminogen activation in human serum by Hedner (1973)10.1016/0049-3848(78)90057-9
/ Thromb. Res. / Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of plasminogen activation (PA-inhibitor) by Hedner (1978)10.1016/S0021-9258(17)32973-3
/ J. Biol. Chem. / Inhibition of activated factor XII by antithrombin-heparin cofactor by Stead (1976)10.1172/JCI106962
/ J. Clin. Invest. / Inhibitors of kallikrein in human plasma by McConnell (1972){'key': '10.1016/S1040-8428(86)80014-2_bib45', 'article-title': 'Mechanism of Activation and Effect of Plasmin in Blood', 'author': 'Müllertz', 'year': '1956'}
/ Mechanism of Activation and Effect of Plasmin in Blood by Müllertz (1956)10.1182/blood.V46.4.555.555
/ Blood / The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator from cadaver limbs by Gurewich (1975){'key': '10.1016/S1040-8428(86)80014-2_bib47', 'first-page': '571', 'article-title': 'Temporarily increased inhibition by plasma of plasminogen activator activity in severely ill patients', 'volume': '12', 'author': 'Wijngaards', 'year': '1982', 'journal-title': 'Haemostasis'}
/ Haemostasis / Temporarily increased inhibition by plasma of plasminogen activator activity in severely ill patients by Wijngaards (1982)10.1016/0049-3848(83)90407-3
/ Thromb. Res. / Evidence for a rapid inhibitor to tissue plasminogen activator in plasma by Chmielewska (1983)10.1055/s-0038-1661109
/ Thromb. Haemost. / Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma by Verheijen (1984){'key': '10.1016/S1040-8428(86)80014-2_bib50', 'first-page': '365', 'article-title': 'Inhibition of tissue plasminogen activator by human plasma', 'volume': 'Vol. 6', 'author': 'Kruithof', 'year': '1983'}
/ Inhibition of tissue plasminogen activator by human plasma by Kruithof (1983)10.1016/0049-3848(84)90018-5
/ Thromb. Res. / Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions by Juhan-Vague (1984)10.1111/j.1432-1033.1976.tb10875.x
/ Eur. J. Biochem. / Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma by Collen (1976)10.1016/S0021-9258(17)33045-4
/ J. Biol. Chem. / Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis by Moroi (1976)10.1042/bj1590545
/ Biochem. J. / The primary inhibitor of plasmin in human plasma by Müllertz (1976)10.1016/0300-9432(76)90015-7
/ Forensic Sci. / Purification and characterization of an inhibitor of plasminogen activation from posttraumatic patients by Bagge (1976){'key': '10.1016/S1040-8428(86)80014-2_bib56', 'series-title': 'Report on the joint meeting of the task forces on nomenclature and standards of inhibitors of coagulation and fibrinolysis', 'first-page': '524', 'volume': '39', 'author': 'Hedner', 'year': '1978'}
/ Report on the joint meeting of the task forces on nomenclature and standards of inhibitors of coagulation and fibrinolysis by Hedner (1978)10.1042/bj1430273
/ Biochem. J. / Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin by Müllertz (1974)10.3109/00365516709076931
/ Scand. J. Clin. Lab. Invest. / Plasmin, plasmin inhibitors and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase by Nilehn (1967)10.1182/blood.V51.4.563.563
/ Blood / Fast-acting plasmin inhibitor in human plasma by Collen (1978){'key': '10.1016/S1040-8428(86)80014-2_bib60', 'first-page': '1', 'article-title': 'Fibrinolysis—an overview', 'volume': 'Vol. 3', 'author': 'Astrup', 'year': '1978'}
/ Fibrinolysis—an overview by Astrup (1978){'key': '10.1016/S1040-8428(86)80014-2_bib61', 'series-title': 'Proteases and Biological Control', 'first-page': '333', 'article-title': 'Plasminogen activator: secretion by neoplastic cell and macrophages', 'author': 'Reich', 'year': '1975'}
/ Proteases and Biological Control / Plasminogen activator: secretion by neoplastic cell and macrophages by Reich (1975)10.1016/S0065-7743(08)60781-2
/ Annu. Rep. Med. Chem. / Plasminogen activators by Goldfarb (1983)10.1016/0277-5379(84)90001-4
/ Eur. J. Cancer Clin. Oncol. / Plasminogen activator and cancer. A review by Duffy (1984){'key': '10.1016/S1040-8428(86)80014-2_bib64', 'series-title': 'Regulatory Proteolytic Enzymes and Their Inhibitors', 'first-page': '181', 'article-title': 'Studies on the role of plasminogen activator in ovulation and early embryogenesis', 'author': 'Strickland', 'year': '1978'}
/ Regulatory Proteolytic Enzymes and Their Inhibitors / Studies on the role of plasminogen activator in ovulation and early embryogenesis by Strickland (1978){'key': '10.1016/S1040-8428(86)80014-2_bib65', 'first-page': '191', 'article-title': 'The primary structure of human plasminogen: isolation of two lysine-binding fragments and one “mini”-plasminogen (M.W. 38,000) by elastase-catalyzed-specific limited proteolysis', 'volume': 'Vol. 3', 'author': 'Sottrup-Jensen', 'year': '1978'}
/ The primary structure of human plasminogen: isolation of two lysine-binding fragments and one “mini”-plasminogen (M.W. 38,000) by elastase-catalyzed-specific limited proteolysis by Sottrup-Jensen (1978){'key': '10.1016/S1040-8428(86)80014-2_bib66', 'first-page': '91', 'volume': 'Vol. 5', 'author': 'Sottrup-Jensen', 'year': '1978'}
by Sottrup-Jensen (1978)10.1111/j.1432-1033.1977.tb11578.x
/ Eur. J. Biochem. / Primary structure of the B-chain of human plasmin by Wiman (1977){'key': '10.1016/S1040-8428(86)80014-2_bib68', 'first-page': '56', 'article-title': 'Cloning and structural characterization of the gene for human plasminogen', 'volume': '14', 'author': 'Sadler', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Cloning and structural characterization of the gene for human plasminogen by Sadler (1984){'key': '10.1016/S1040-8428(86)80014-2_bib69', 'series-title': 'Chromogenic Peptide Substrates', 'first-page': '128', 'article-title': 'Plasminogen determination in human plasma', 'author': 'Friberger', 'year': '1979'}
/ Chromogenic Peptide Substrates / Plasminogen determination in human plasma by Friberger (1979){'key': '10.1016/S1040-8428(86)80014-2_bib70', 'first-page': '20', 'article-title': 'Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations', 'volume': '221', 'author': 'Wallen', 'year': '1970', 'journal-title': 'Biochim. Biophys. Acta'}
/ Biochim. Biophys. Acta / Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations by Wallen (1970)10.1016/0005-2795(72)90261-9
/ Biochim. Biophys. Acta / Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen by Wallen (1972)10.1126/science.170.3962.1095
/ Science / Plasminogen: purification from human plasma by affinity chromatography by Deutsch (1970){'key': '10.1016/S1040-8428(86)80014-2_bib73', 'series-title': 'Fibrinolysis, Current Fundamental and Clinical Aspects', 'first-page': '47', 'article-title': 'Biochemistry of the plasminogen to plasmin conversion', 'author': 'Wiman', 'year': '1978'}
/ Fibrinolysis, Current Fundamental and Clinical Aspects / Biochemistry of the plasminogen to plasmin conversion by Wiman (1978)10.1016/0003-9861(72)90488-2
/ Arch. Biochem. Biophys. / Measurement of the binding of antifibrinolytic amino acids to various plasminogens by Brockway (1972)10.1055/s-0038-1651398
/ Thromb. Diath. Haemorrh. / Molecular biology of human plasminogen. I. Physicochemical properties and microheterogeneity by Collen (1975)10.1016/0006-291X(73)90170-8
/ Biochem. Biophys. Res. Commun. / Amino terminal amino acid sequences and carbohydrate of the two major forms of rabbit plasminogen by Castellino (1973)10.1016/S0021-9258(19)45042-4
/ J. Biol. Chem. / Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods by Summaris (1972)10.1016/S0021-9258(19)86763-7
/ J. Biol. Chem. / Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation and characterization by Hayes (1979)10.1016/S0021-9258(19)86764-9
/ J. Biol. Chem. / Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit by Hayes (1979)10.1016/S0021-9258(19)86765-0
/ J. Biol. Chem. / Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit by Hayes (1979)10.1111/j.1432-1033.1981.tb05682.x
/ Eur. J. Biochem. / On the role of the carbohydrate side chains of human plasminogen in its interactions with alpha2-antiplasmin and fibrin by Lijmen (1981){'key': '10.1016/S1040-8428(86)80014-2_bib82', 'article-title': 'Plasminogen and Prothrombin Metabolism in Man', 'author': 'Collen', 'year': '1974'}
/ Plasminogen and Prothrombin Metabolism in Man by Collen (1974)10.1055/s-0038-1651399
/ Thromb. Diath. Haemorrh. / Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in man by Collen (1975)10.1016/S0021-9258(18)95967-3
/ J. Biol. Chem. / The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin by Robbias (1967){'key': '10.1016/S1040-8428(86)80014-2_bib85', 'first-page': '3590', 'article-title': 'Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue', 'volume': '244', 'author': 'Greskepf', 'year': '1969', 'journal-title': 'J. Biol. Chem.'}
/ J. Biol. Chem. / Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue by Greskepf (1969)10.1016/0005-2795(74)90090-7
/ Biochim. Biophys. Acta / Physico-chemical and proenzyme properties of NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid by Claeys (1974){'key': '10.1016/S1040-8428(86)80014-2_bib87', 'series-title': 'Proteases and Biological Control', 'first-page': '291', 'article-title': 'On the generation of intermediate plasminogen and its significance for activation', 'author': 'Wallen', 'year': '1975'}
/ Proteases and Biological Control / On the generation of intermediate plasminogen and its significance for activation by Wallen (1975)10.1055/s-0038-1647702
/ Thromb. Diath. Haemorrh. / Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid by Thorsen (1974)10.1016/0005-2795(73)90106-2
/ Biochim. Biophys. Acta / Release of an N-terminal peptide from human plasminogen during activation with urokinase by Rickli (1973)10.1111/j.1432-1033.1973.tb02880.x
/ Eur. J. Biochem. / Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound by Wiman (1973){'key': '10.1016/S1040-8428(86)80014-2_bib91', 'first-page': '3988', 'article-title': 'The activation of plasminogen, to plasmin by urokinase in the presence of the plasmin inhibitor trasylol. The preparation of plasmin, with the same NH2-terminal heavy (A) chain sequence as the parent zymogen', 'volume': '250', 'author': 'Summaria', 'year': '1975', 'journal-title': 'J. Biol. Chem.'}
/ J. Biol. Chem. / The activation of plasminogen, to plasmin by urokinase in the presence of the plasmin inhibitor trasylol. The preparation of plasmin, with the same NH2-terminal heavy (A) chain sequence as the parent zymogen by Summaria (1975)10.1016/S0021-9258(17)33334-3
/ J. Biol. Chem. / Mechanism of the urokinase-catalyzed activation of human plasminogen by Vloland (1976)10.1016/S0021-9258(19)86843-6
/ J. Biol. Chem. / On the mechanism of the reaction between human alpha2-antiplasmin and plasmin by Wiman (1979){'key': '10.1016/S1040-8428(86)80014-2_bib94', 'article-title': 'Reaction sequences and the mechanism of plasminogen activation in urokinase-activated plasma. Effects of fibrin and 6-aminohexanoic acid', 'volume': 'Vol. 4', 'author': 'Thorsen', 'year': '1979'}
/ Reaction sequences and the mechanism of plasminogen activation in urokinase-activated plasma. Effects of fibrin and 6-aminohexanoic acid by Thorsen (1979)10.1016/0005-2744(77)90297-2
/ Biochim. Biophys. Acta / Kinetic studies of the urokinase-cataylsed conversion of NH2-terminal glutamic acid plasminogen to plasmin by Christensen (1977)10.1016/S0021-9258(17)34880-9
/ J. Biol. Chem. / Steady state kinetics of activation of human and bovine plasminogens by streptokinase and its equimolar complexes with various activated forms of human plasmingen by Wohl (1978)10.1093/oxfordjournals.jbchem.a133453
/ J. Biochem. / A comparative study of high molecular weight urokinase and low molecular weight urokinase by Nobuhara (1981)10.1021/bi00540a035
/ Biochemistry / Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids by Peltz (1982)10.1016/0167-4838(83)90165-6
/ Biochim. Biophys. Acta / Comparative activation kinetics of mammalian plasminogen by Wohi (1983){'key': '10.1016/S1040-8428(86)80014-2_bib100', 'first-page': '269', 'article-title': 'Influence of modified plasminogens and different buffers on the determination of tissue plasminogen activator with a spectrophotometric assay in the presence of polylysine', 'volume': '50', 'author': 'Eriksson', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Influence of modified plasminogens and different buffers on the determination of tissue plasminogen activator with a spectrophotometric assay in the presence of polylysine by Eriksson (1983)10.1016/0005-2744(77)90340-0
/ Biochim. Biophys. Acta / Kinetic studies on the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin by Christensen (1977)10.1016/S0021-9258(17)38164-4
/ J. Biol. Chem. / Comparison of some properties of native (Glu) and modified (Lys), human plasminogen by Markus (1978)10.1016/S0021-9258(19)41141-1
/ J. Biol. Chem. / The importance of the preactivation peptide in two stage mechanism of human plasminogen activation by Walther (1975)10.1021/bi00739a002
/ Biochemistry / Rotational diffusion analysis of the conformational alterations produced in plasminogen by certain antifibrinolytic amino acids by Castellino (1973)10.1111/j.1432-1033.1973.tb03146.x
/ Eur. J. Biochem. / Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid by Sjoholm (1973)10.1016/S0021-9258(17)30384-8
/ J. Biol. Chem. / The effect of alpha, omega-amino acids on human plasminogen structure and activation by Violand (1978)10.3109/00365517409050831
/ Scand. J. Clin. Lab. Invest. / Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds by Thorsen (1974)10.3181/00379727-138-35878
/ Proc. Soc. Exp. Biol. Med. / Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin by Camiolo (1971)10.1016/S0021-9258(17)44152-4
/ J. Biol. Chem. / The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity by Lucas (1983)10.1111/j.1432-1033.1984.tb08499.x
/ Eur. J. Biochem. / Influence of cyanogen bromide-digested fibrinogen on the kinetics of, plasminogen activation by urokinase by Lijnen (1984)10.1021/bi00533a021
/ Biochemistry / Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products by Strickland (1982){'key': '10.1016/S1040-8428(86)80014-2_bib112', 'series-title': 'Thrombosis and Urokinase', 'first-page': '91', 'article-title': 'Activation of plasminogen with urokinase and tissue activator', 'author': 'Wallen', 'year': '1977'}
/ Thrombosis and Urokinase / Activation of plasminogen with urokinase and tissue activator by Wallen (1977)10.1016/S0021-9258(19)81052-9
/ J. Biol. Chem. / Fibrinolytic properties of one-chain and two-chain human extinsic (tissue-type) plasminogen activator by Rijken (1982)10.1016/S0021-9258(19)81051-7
/ J. Biol. Chem. / Kinetics of the activation of plasminogen human tissue plasminogen activator. Role of fibrin by Hoylaerts (1982)10.1016/S0021-9258(17)43319-9
/ J. Biol. Chem. / Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator by Zamarron (1984)10.1016/0167-4838(82)90068-1
/ Biochim. Biophys. Acta / Studies on the kinetics of plasminogen activation by tissue plasminogen activator by Ranby (1982){'key': '10.1016/S1040-8428(86)80014-2_bib117', 'first-page': '71', 'article-title': 'Kinetics of plasminogen activation by 1-PA; the role of fibrinogen fragments', 'volume': '14', 'author': 'Nieuwenhulzen', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Kinetics of plasminogen activation by 1-PA; the role of fibrinogen fragments by Nieuwenhulzen (1984)10.1111/j.1432-1033.1984.tb08132.x
/ Eur. J. Biochem. / Initial plasmin-degradation of fibrin as the basis of a positive feedback mechanism in fibrinolysis by Suenson (1984){'key': '10.1016/S1040-8428(86)80014-2_bib119', 'first-page': '182', 'article-title': 'Tissue plasminogen activator kinetics', 'volume': 'Vol. 6', 'author': 'Ranby', 'year': '1983'}
/ Tissue plasminogen activator kinetics by Ranby (1983)10.1042/bj0930171
/ Biochem. J. / The purification and properties of human plasminogen by Alkjaersig (1964)10.1016/0005-2744(69)90435-5
/ Biochim. Biophys. Acta / Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor by Abiko (1969)10.1111/j.1432-1033.1980.tb04461.x
/ Eur. J. Biochem. / Studies on the lysine-binding sites of human plasminogen. The effect of ligand structure on the binding of lysine analogs to plasminogen by Winn (1980)10.1111/j.1432-1033.1980.tb04617.x
/ Eur. J. Biochem. / Localization of individual lysine-binding regions in human plasminogen and investigation in their complex-forming properties by Lerch (1980)10.1016/0304-4165(81)90312-3
/ Biochim. Biophys. Acta / Studies on the mechanism of the antifibrinolytic action of tranexamic acid by Hoylaerts (1981)10.1016/S0021-9258(17)38163-2
/ J. Biol. Chem. / Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen by Markus (1978)10.1016/S0021-9258(17)34189-3
/ J. Biol. Chem. / The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation by Markus (1979)10.1111/j.1432-1033.1975.tb02472.x
/ Eur. J. Biochem. / A new method of isolation and some properties of heavy chain of human plasmin by Rickli (1975)10.1016/0005-2795(79)90094-1
/ Biochim. Biophys. Acta / On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen by Wiman (1979)10.1016/S0021-9258(19)68152-4
/ J. Biol. Chem. / Location of the intermediate and high affinity omega-aminocarboxylic acid binding sites in human plasminogen by Vali (1982)10.1016/S0021-9258(18)34391-6
/ J. Biol. Chem. / Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4 by Trexler (1982)10.1016/0014-5793(83)80173-2
/ FEBS Lett. / The solution structure of kringle 4, NMR studies on native and several chemically mudified kringle 4 species of human plasminogen by Trexler (1983)10.1016/S0021-9258(19)68524-8
/ J. Biol. Chem. / Immunochemical characterization of a low affinity lysine binding site within plasminogen by Plow (1981)10.1016/0005-2795(75)90216-0
/ Biochim. Biophys. Acta / Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-amino-carboxylic acids by Thorsen (1975)10.1016/0304-4165(78)90142-3
/ Biochim. Biophys. Acta / On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin by Rakoczi (1978)10.1111/j.1432-1033.1975.tb09887.x
/ Eur. J. Biochem. / Structural relationship between “glutamic acid” and “lysine” forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography by Wiman (1975)10.1016/0049-3848(77)90003-2
/ Thromb. Res. / The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen by Wiman (1977)10.1042/bj2230413
/ Biochem. J. / The AH-site of plasminogen and two C-terminal fragments. A weak lysinc-binding site preferring ligands not carrying a free carboxylate function by Christensen (1984)10.1038/272549a0
/ Nature (London) / Molecular mechanism of physiological fibrinolysis by Wiman (1978)10.1055/s-0038-1650023
/ Thromb. Haemost. / On the regulation and control of fibrinolysis by Collen (1980){'key': '10.1016/S1040-8428(86)80014-2_bib140', 'series-title': 'Synthetic Substrates in Clinical Blood Coagulation Assays', 'first-page': '113', 'article-title': 'New prospects in the activation of fibrinolysis', 'author': 'Kluft', 'year': '1980'}
/ Synthetic Substrates in Clinical Blood Coagulation Assays / New prospects in the activation of fibrinolysis by Kluft (1980){'key': '10.1016/S1040-8428(86)80014-2_bib141', 'first-page': '219', 'article-title': 'Influence of operative trauma on factor XII and inhibitor of plasminogen activator', 'volume': '13', 'author': 'Hedner', 'year': '1983', 'journal-title': 'Haemostasis'}
/ Haemostasis / Influence of operative trauma on factor XII and inhibitor of plasminogen activator by Hedner (1983){'key': '10.1016/S1040-8428(86)80014-2_bib142', 'series-title': 'Haemostasis: Biochemistry, Physiology and Pathology', 'first-page': '25', 'article-title': 'The surface-mediated initiation of blood coagulation and related phenomena', 'author': 'Ratnoff', 'year': '1977'}
/ Haemostasis: Biochemistry, Physiology and Pathology / The surface-mediated initiation of blood coagulation and related phenomena by Ratnoff (1977)10.1021/bi00871a003
/ Biochemistry / The isolation and characterization of plasminogen activators (urokinase) from human urine by White (1966)10.1515/bchm2.1982.363.1.133
/ Hoppe-Seyler's Z. Physiol. Chem. / Structural relationship between human high and low molecular mass urokinase by Gunzler (1982)10.1515/bchm2.1982.363.2.1155
/ Hoppe-Seyler's Z. Physiol. Chem. / The primary structure of high molecular mass urokinase from human urine by Gunzler (1982)10.1111/j.1432-1033.1984.tb08135.x
/ Eur. J. Biochem. / A specific disulfide bond associated with the activity of human urokinase by Miwa (1984)10.1172/JCI107246
/ J. Clin. Invest. / Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition by Bernik (1973)10.1016/0304-4165(77)90321-X
/ Biochim. Biophys. Acta / Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator by Nolan (1977)10.1021/bi00268a014
/ Biochemistry / Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody by Nielsen (1982){'key': '10.1016/S1040-8428(86)80014-2_bib150', 'first-page': '119', 'article-title': 'Physiocochemical properties of highly purified kidney cultured plasminogen activator (single polypeptide chain-urokinase)', 'volume': '45', 'author': 'Sumi', 'year': '1982', 'journal-title': 'Acta Haematol. japon.'}
/ Acta Haematol. japon. / Physiocochemical properties of highly purified kidney cultured plasminogen activator (single polypeptide chain-urokinase) by Sumi (1982)10.1016/0003-9861(83)90383-1
/ Arch. Biochim. Biophys. / Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine by Husain (1983)10.1016/S0021-9258(18)34566-6
/ J. Biol. Chem. / A proenzyme form of human urokinase by Wun (1982)10.1038/nbt0784-628
/ Biotechnology / Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity by Kohno (1984){'key': '10.1016/S1040-8428(86)80014-2_bib154', 'first-page': '165', 'article-title': 'Comparative properties of single and double polypeptide chains of high molecular weight urokinase', 'volume': 'Vol. 6', 'author': 'Sumi', 'year': '1983'}
/ Comparative properties of single and double polypeptide chains of high molecular weight urokinase by Sumi (1983)10.1172/JCI111381
/ J. Clin. Invest. / Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species by Gurewich (1984)- Heyneker H. L., Holmes, W. E., and Vehar, G. A. Preparation of Functional Human Urokinase Proteins, European Patent Application nr. 83103629.8, Publication nr. 0092182A2, European Patent Office, Munich, West Germany.
10.1055/s-0038-1661127
/ Thromb. Haemost. / Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinase obtained from human urine or by recombinant DNA technology by Zamarron (1984)10.1055/s-0038-1661129
/ Thromb. Haemost. / Biological and thrombolytic properties of proenzyme and active forms of human urokinase. III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis by Collen (1984){'key': '10.1016/S1040-8428(86)80014-2_bib159', 'first-page': '42', 'article-title': 'Tissue activators of plasminogen', 'volume': '25', 'author': 'Astrup', 'year': '1966', 'journal-title': 'Fed. Proc.'}
/ Fed. Proc. / Tissue activators of plasminogen by Astrup (1966){'key': '10.1016/S1040-8428(86)80014-2_bib160', 'first-page': '713', 'article-title': 'The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravenous infusion', 'volume': '65', 'author': 'Fletcher', 'year': '1965', 'journal-title': 'J. Lab. Clin. Med.'}
/ J. Lab. Clin. Med. / The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravenous infusion by Fletcher (1965){'key': '10.1016/S1040-8428(86)80014-2_bib161', 'first-page': '367', 'article-title': 'Urokinase inactivation rate in the rabbit: effect of circulatory isolation of the liver, spleen and kidneys', 'volume': '7', 'author': 'Matsuo', 'year': '1978', 'journal-title': 'Haemostasis'}
/ Haemostasis / Urokinase inactivation rate in the rabbit: effect of circulatory isolation of the liver, spleen and kidneys by Matsuo (1978)10.1055/s-0038-1661128
/ Thromb. Haemost. / Biological and thrombolytic properties of proenzyme and active forms of human urokkinase. II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys by Collen (1984)10.1042/cs0440073
/ Clin Sci. / The inhibition of urokinase by alpha2-macroglobulin by Ogston (1973)10.1016/0005-2744(76)90307-7
/ Biochim. Biophys. Acta / Inhibition of urokinase by complex formation with human alpha1-antitrypsin by Clemmensen (1976)10.1055/s-0038-1646735
/ Thromb. Haemost. / Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of herparin by Clemmensen (1978)10.1055/s-0038-1657120
/ Thromb. Haemost. / Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin by Samama (1982)10.1093/oxfordjournals.bmb.a071491
/ Br. Med. Bull. / Thrombolytic therapy by Kakkar (1978){'key': '10.1016/S1040-8428(86)80014-2_bib168', 'series-title': 'Thrembosis and Urokinase', 'year': '1977'}
/ Thrembosis and Urokinase (1977){'key': '10.1016/S1040-8428(86)80014-2_bib169', 'series-title': 'Fibrinolysis', 'first-page': '129', 'article-title': 'A far-reaching program: rapid, safe and predictable thrombolysis in man', 'author': 'Verstraete', 'year': '1980'}
/ Fibrinolysis / A far-reaching program: rapid, safe and predictable thrombolysis in man by Verstraete (1980)10.3181/00379727-82-20087
/ Proc. Soc. Exp. Biol. Med. / An activator system in blood indispensable for the formation of plasmin by streptokinase by Müllertz (1953)10.1021/bi00691a018
/ Biochemistry / Kinetic mechanism of the activation of human plasminogen by streptokinase by Kosow (1975)10.1016/S0021-9258(17)38115-2
/ J. Biol. Chem. / Mechanism of activation of human plasminogen by the activator complex, streptokinase-plasmin by Gonzales-Gronow (1978)10.1111/j.1432-1033.1979.tb02040.x
/ Eur. J. Biochem. / Kinetics of the reactions between streptokinase, plasmin and alpha2-antiplasmin by Cederholm-Williams (1979)10.1136/bmj.1.5485.454
/ Br. Med. J. / Thrombolytic therapy with streptokinase using a standard dosage scheme by Verstraete (1966)10.1172/JCI103941
/ J. Clin. Invest. / The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase by Johnson (1959)10.1016/0005-2795(80)90176-2
/ Biochim. Biophys. Acta / Purification and characterization of human vascular plasminogen activator by Astedt (1980)10.1055/s-0038-1650126
/ Thromb. Haemost. / Isolation and properties of human vascular plasminogen activator by Allen (1981)10.1016/S0021-9258(19)69095-2
/ J. Biol. Chem. / Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture by Rijken (1981)10.1055/s-0038-1657284
/ Thromb. Haemost. / Purification of human tissue-type plasminogen activator in centrigram quantities from human melanoma cell cultare fluid and its conditioning for use in vivo by Collen (1982){'key': '10.1016/S1040-8428(86)80014-2_bib180', 'first-page': '98', 'article-title': 'Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells', 'volume': 'Vol. 2', 'author': 'Kluft', 'year': '1984'}
/ Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells by Kluft (1984)10.1111/j.1432-1033.1983.tb07418.x
/ Eur. J. Biochem. / Purification and characterization of a melanoma cell plasminogen activator by Wallea (1983)10.1002/j.1460-2075.1983.tb01391.x
/ EMBO J. / Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification by Niehem (1983)10.1038/301214a0
/ Nature (London) / Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli by Pennica (1983){'key': '10.1016/S1040-8428(86)80014-2_bib184', 'first-page': '146', 'article-title': 'Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells', 'volume': '231', 'author': 'Collen', 'year': '1984', 'journal-title': 'J. Pharm. Exp. Ther.'}
/ J. Pharm. Exp. Ther. / Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells by Collen (1984)10.1016/0304-4165(82)90105-2
/ Biochim. Biophys. Acta. / Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin by Wallea (1982)10.1016/0014-5793(83)80551-1
/ FEBS Lett. / Adaptation of plasminogen activator sequences to knowa protease structures by Stramburger (1983)10.1016/0014-5793(83)81157-0
/ FEBS Lett. / Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator by Banyal (1983)10.1073/pnas.80.2.349
/ Proc. Natl. Acad. Sci. U.S.A. / Isolation of cDNA sequences coding for a part of human tissue plasminogen activator by Edlund (1983){'key': '10.1016/S1040-8428(86)80014-2_bib189', 'first-page': '56', 'article-title': 'Isolation and characterization of the genomic region carrying the human tissue plasminogen activator gene', 'volume': '14', 'author': 'Ny', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Isolation and characterization of the genomic region carrying the human tissue plasminogen activator gene by Ny (1984)10.1016/0049-3848(82)90197-9
/ Thromb. Res. / Enzymatic properties of one-chain and two-chain forms of tissue plasminogen activator by Ranby (1982)10.1016/0014-5793(82)80936-8
/ FEBS Lett. / Isolation of two variants of native one-chain tissue plasminogen activator by Ranby (1982){'key': '10.1016/S1040-8428(86)80014-2_bib192', 'first-page': '106', 'article-title': 'Two forms of tissue-type plasminogen activator differ at a single specific glycosylation site', 'volume': '50', 'author': 'Bennett', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Two forms of tissue-type plasminogen activator differ at a single specific glycosylation site by Bennett (1983){'key': '10.1016/S1040-8428(86)80014-2_bib193', 'first-page': '17', 'article-title': 'Elastase treatment reveals functional differences between two variants of tissue plasminogen activator', 'volume': '14', 'author': 'Pohl', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Elastase treatment reveals functional differences between two variants of tissue plasminogen activator by Pohl (1984)10.1016/0014-5793(83)80245-2
/ FEBS Lett. / Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneity by Jornvall (1983){'key': '10.1016/S1040-8428(86)80014-2_bib195', 'first-page': '65', 'article-title': 'Control mechanism of activator release', 'volume': 'Vol. 3', 'author': 'Cash', 'year': '1978'}
/ Control mechanism of activator release by Cash (1978)10.1111/j.1365-2141.1984.tb06092.x
/ Br. J. Haematol. / Identification of plasminogen activator releasing activity in the neurohypophysis by Colucci (1984)10.1172/JCI110368
/ J. Clin. Invest. / Generation of fibrinolytic activity by infusion of activated protein C into dogs by Comp (1981)10.1172/JCI111402
/ J. Clin. Invest. / Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys by Colucci (1984)10.1016/0092-8674(81)90363-9
/ Cell / Inhibition of plasminogen activator release from transformed chicken fibroblasts by a protease inhibitor by O'Donnell-Torney (1981)10.1073/pnas.80.2.344
/ Proc. Natl. Acad. Sci. U.S.A. / Detection and partial characterization of chymostatin-sensitive endopeptidase in transformed fibroblasts by O'Donnell-Tormey (1983)10.1016/S0065-230X(08)60361-9
/ Adv. Cancer Res. / Shedding from the cell surface of normal and cancer cells by Black (1980)10.1016/0014-4827(82)90252-X
/ Exp. Cell Res. / Regulation of protein secretion in Chinese hamster ovary cells by cell cycle position and cell density. Plasminogen activator, procollagen, fibronectin by Aggeler (1982)10.1055/s-0038-1653442
/ Thromb. Haemost. / Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits by Korninger (1981){'key': '10.1016/S1040-8428(86)80014-2_bib204', 'first-page': '90', 'article-title': 'Turnover of tissue-type plasminogen activator in man', 'volume': '14', 'author': 'Nilsson', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Turnover of tissue-type plasminogen activator in man by Nilsson (1984){'key': '10.1016/S1040-8428(86)80014-2_bib205', 'first-page': '285', 'article-title': 'Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay', 'volume': '101', 'author': 'Rijken', 'year': '1983', 'journal-title': 'J. Lab. Clin. Med.'}
/ J. Lab. Clin. Med. / Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay by Rijken (1983){'key': '10.1016/S1040-8428(86)80014-2_bib206', 'first-page': '65', 'article-title': 'Extrinsic plasminogen activator levels in clinical plasma samples', 'volume': 'Vol. 6', 'author': 'Juhan-Vague', 'year': '1983'}
/ Extrinsic plasminogen activator levels in clinical plasma samples by Juhan-Vague (1983)10.1016/S0021-9258(17)43143-7
/ J. Biol. Chem. / Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor by Wiman (1984)10.1182/blood.V64.4.907.907
/ Blood / Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma by Kruithof (1986)10.1016/0006-291X(83)91161-0
/ Biochem. Biophys. Res. Commun. / Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells by Emels (1983)10.1016/S0021-9258(19)69406-8
/ J. Biol. Chem. / An inhibitor of plasminogen activator in rabbit endothelial cells by Luskwtoff (1981)10.1172/JCI111559
/ J. Clin. Invest. / Detection and partial characterization of an inhibitor of plasminogen activator in human platelets by Erickson (1984)10.1055/s-0038-1661250
/ Thromb. Haemost. / Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator by stedt (1985){'key': '10.1016/S1040-8428(86)80014-2_bib213', 'first-page': '94', 'article-title': 'Inhibition of tissue-type plasminogen activator inhibitor activity by activated protein C', 'volume': '70', 'author': 'Bertina', 'year': '1984', 'journal-title': 'Circulation'}
/ Circulation / Inhibition of tissue-type plasminogen activator inhibitor activity by activated protein C by Bertina (1984)10.1016/0049-3848(82)90012-3
/ Thromb. Res. / A sensitive assay for tissue plasminogen activator by Ranby (1982)10.1016/0304-4165(83)90261-1
/ Biochim. Biophys. Acta. / Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2 by Nieuwenhuizen (1983)10.1016/0167-4838(83)90030-4
/ Biochim. Biophys. Acta / Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator by Nieuwenhulzen (1983)10.1016/0003-9861(81)90512-9
/ Arch. Biochem. Biophys. / Stimulation of tissue plasminogen activator by denatured proteins and fibrin clost: a possible additional role for plasminogen activator by Radcliffe (1981)10.1016/0167-4838(83)90401-6
/ Biochim. Biophys. Acta / A critical role of lysine residues in the stimulation of tissue plasminogen activator by denatured proteins and fibrin clots by Radcliffe (1983)10.1084/jem.108.1.53
/ J. Exp. Med. / Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma by Norman (1958)10.1084/jem.108.5.639
/ J. Exp. Med. / Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma by Norman (1958)10.1016/S0021-9258(18)99676-6
/ J. Biol. Chem. / The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin and thrombin by Rimon (1966){'key': '10.1016/S1040-8428(86)80014-2_bib222', 'first-page': '1', 'article-title': 'Antiproteasen des Humanserums', 'volume': '21', 'author': 'Schwick', 'year': '1966', 'journal-title': 'Z. Inn. Med.'}
/ Z. Inn. Med. / Antiproteasen des Humanserums by Schwick (1966)10.1182/blood.V51.4.563.563
/ Blood / Fast-acting plasmin inhibitor in human plasma by Collen (1978)10.1016/0033-0620(79)90014-8
/ Prog. Cardiovasc. Dis. / Natural inhibitors of fibrinolysis by Aoki (1979){'key': '10.1016/S1040-8428(86)80014-2_bib225', 'series-title': 'The Physiological Inhibitors of Blood Coagulation and Fibrinolysis', 'first-page': '87', 'article-title': 'The primary plasmin inhibitor, alpha2-plasmin inhibitor or alpha2-antiplasmin: a review', 'author': 'Müllertz', 'year': '1979'}
/ The Physiological Inhibitors of Blood Coagulation and Fibrinolysis / The primary plasmin inhibitor, alpha2-plasmin inhibitor or alpha2-antiplasmin: a review by Müllertz (1979)10.1016/S0076-6879(81)80034-1
/ Methods Enzymol. / Human alpha2-antiplasmin by Wiman (1981)10.3109/00365517209080272
/ Scand. J. Clin. Lab. Invest. / Molecular forms of plasmin and protease inhibitors in human fibrinolytic postmortem plasma by Müllertz (1972)10.1152/ajplegacy.1971.220.4.1137
/ Am. J. Physiol. / Human serum plasminogen antiactivator: its distinction from antiplasmin by Aoki (1971)10.1016/0049-3848(73)90087-X
/ Thromb. Res. / Metabolism of iodine-labeled plasminogen during steptokinase and reptilase therapy in man by Collen (1973)10.1016/0049-3848(75)90142-5
/ Thromb. Res. / Immunochemical distinction between antiplasmin and alpha1-antitrypsin by Collen (1975)10.1016/0049-3848(77)90045-7
/ Thromb. Res. / Further evidence for the presence of two plasma inhibitors of fibrinolysis distinct from alpha2-macroglobulin by Gallimore (1977)10.1016/0049-3848(78)90242-6
/ Thromb. Res. / The primary fibrinolysis inhibitor and trauma by Bagge (1978)10.1055/s-0038-1646660
/ Thromb. Haemost. / Purification of a fibrinolysis inhibitor in serum from posttraumatic patients by Bagge (1978){'key': '10.1016/S1040-8428(86)80014-2_bib234', 'series-title': 'The Microembolism Syndrome', 'first-page': '169', 'article-title': 'Inhibition of plasminogen activation by the primary fibrinolysis inhibitor (alpha2-plasmin inhibitor)', 'author': 'Bagge', 'year': '1978'}
/ The Microembolism Syndrome / Inhibition of plasminogen activation by the primary fibrinolysis inhibitor (alpha2-plasmin inhibitor) by Bagge (1978){'key': '10.1016/S1040-8428(86)80014-2_bib235', 'first-page': '149', 'article-title': 'Purification and characterisation of a fibrinolysis inhibitor', 'volume': '10', 'author': 'Saldeen', 'year': '1977', 'journal-title': 'Forensic Sci.'}
/ Forensic Sci. / Purification and characterisation of a fibrinolysis inhibitor by Saldeen (1977)10.1016/0049-3848(76)90016-5
/ Thromb. Res. / Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma by Hedner (1976)10.1111/j.1365-2141.1975.tb00852.x
/ Br. J. Haematol. / Serum inhibitors of fibrinolysis by Gallimore (1975)10.1016/0049-3848(78)90259-1
/ Thromb. Res. / Inter-alpha-antiplasmin: its distinction from antiactivator by Gallimore (1978){'key': '10.1016/S1040-8428(86)80014-2_bib239', 'first-page': '249', 'article-title': 'Studies on fibrinolytic inhibitors', 'volume': 'Vol. 3', 'author': 'Hedner', 'year': '1978'}
/ Studies on fibrinolytic inhibitors by Hedner (1978)10.1055/s-0038-1654213
/ Thromb. Diath. Haemorrh. / Some properties of an antiplasmin substance from rabbit platelets by Wakahayashi (1970)10.1016/0009-8981(72)90068-X
/ Clin. Chim. Acta / A low molecular weight antiplasmin of human blood platelets by Gaeguly (1972)10.1111/j.1365-2141.1975.tb02749.x
/ Br. J. Haematol. / Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum by Mui (1975)10.1016/0005-2795(75)90143-9
/ Biochim. Biophys. Acta / The isolation and characterization of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of anti-urokinase and antiplasmin released from thrombin-aggregated washed human platelets by Moore (1975)10.1182/blood.V58.6.1069.1069
/ Blood / The presence and release of alpha2-antiplasmin from human platelets by Plow (1981)10.1016/0049-3848(83)90339-0
/ Thromb. Res. / Platelet alpha2-antiplasmin is located in the platelet alpha-granules by Gogstad (1983)10.1042/bj1870173
/ Biochem. J. / Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for nonidentity with the known plasma proteinase inhibitors by Sandbjerg-Hansen (1980)10.1111/j.1432-1033.1977.tb11709.x
/ Eur. J. Biochem. / Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma by Wiman (1977)10.1042/bj1750635
/ Biochem. J. / Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma by Christensen (1978)10.1042/bj1910229
/ Biochem. J. / Affinity-chromatographic purification of human alpha2-antiplasmin by Wiman (1980)10.1016/S0021-9258(19)70451-7
/ J. Biol. Chem. / Isolation and characterization of a human plasma protein with affinity for the lysine-binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein by Lijnen (1980){'key': '10.1016/S1040-8428(86)80014-2_bib251', 'first-page': '357', 'article-title': 'Comparison of the partial primary structure of human alpha2-antiplasmin with other plasma protease inhibitors', 'volume': 'Vol. 6', 'author': 'Lijnen', 'year': '1983'}
/ Comparison of the partial primary structure of human alpha2-antiplasmin with other plasma protease inhibitors by Lijnen (1983)10.1016/0049-3848(82)90281-X
/ Thromb. Res. / Purification and partial primary structure of cyanogen bromide fragments from human alpha2-antiplasmin by Lijnen (1982)10.1055/s-0038-1657288
/ Thromb. Haemost. / Partial primary structure of human alpha2-antiplasmin. Homology with other plasma protease inhibitors by Lijnen (1982)10.1016/0167-4838(82)90187-X
/ Biochim. Biophys. Acta / Circular dichroism studies on alpha2-antiplasmin and its interactions with plasmin and plasminogen by Nilsson (1982){'key': '10.1016/S1040-8428(86)80014-2_bib255', 'first-page': '304', 'article-title': 'Conformational properties of two different plasmin/inhibitor complexes', 'volume': 'Vol. 5', 'author': 'Sørensen', 'year': '1981'}
/ Conformational properties of two different plasmin/inhibitor complexes by Sørensen (1981)10.1016/0049-3848(76)90229-2
/ Thromb. Res. / Inhibition of plasmin by normal and antiplasmin-depleted human plasma by Edy (1976){'key': '10.1016/S1040-8428(86)80014-2_bib257', 'first-page': '315', 'article-title': 'Quantitation of the plasma protease inhibitor antiplasmin with the chromogenic substrate S-2251', 'volume': 'Vol. 3', 'author': 'Edy', 'year': '1978'}
/ Quantitation of the plasma protease inhibitor antiplasmin with the chromogenic substrate S-2251 by Edy (1978)10.3109/00365517709091499
/ Scand. J. Clin. Lab. Invest. / Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate by Teger-Nilsson (1977)10.1016/0049-3848(78)90069-5
/ Thromb. Res. / Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate by Naito (1978)10.1016/0049-3848(79)90023-9
/ Thromb. Res. / Studies on the plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate by Gallimore (1979){'key': '10.1016/S1040-8428(86)80014-2_bib261', 'series-title': 'Chromogenic Peptide Substrates—Chemistry and Clinical Usage', 'first-page': '238', 'article-title': 'Discrimination between antiplasmins: reaction mechanisms, biological role and assay of the fast-acting plasmin inhibitor in human plasma', 'author': 'Collen', 'year': '1979'}
/ Chromogenic Peptide Substrates—Chemistry and Clinical Usage / Discrimination between antiplasmins: reaction mechanisms, biological role and assay of the fast-acting plasmin inhibitor in human plasma by Collen (1979)10.1182/blood.V53.2.313.313
/ Blood / Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma by Collen (1979)10.1111/j.1432-1033.1981.tb05675.x
/ Eur. J. Biochem. / Properties of three different molecular forms of the alpha2-plasmin inhibitor by Clemmensen (1981){'key': '10.1016/S1040-8428(86)80014-2_bib264', 'first-page': '170', 'article-title': 'Identification of the plasminogen-binding site of human alpha2-plasmin inhibitor', 'volume': '50', 'author': 'Sasaki', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Identification of the plasminogen-binding site of human alpha2-plasmin inhibitor by Sasaki (1983)10.1016/0049-3848(84)90033-1
/ Thromb. Res. / Demonstration of two forms of alpha2-antiplasmin in plasma by modified crossed immunoelectrophoresis by Kluft (1981)10.1016/0049-3848(82)90261-4
/ Thromb. Res. / Studies on a form of alpha2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen by Wiman (1982){'key': '10.1016/S1040-8428(86)80014-2_bib267', 'first-page': '381', 'article-title': 'On the significance of two forms of human alpha2-antiplasmin with different affinity for the lysine-binding sites in plasminogen', 'volume': 'Vol. 6', 'author': 'Nilsson', 'year': '1983'}
/ On the significance of two forms of human alpha2-antiplasmin with different affinity for the lysine-binding sites in plasminogen by Nilsson (1983){'key': '10.1016/S1040-8428(86)80014-2_bib268', 'first-page': '170', 'article-title': 'The mutual relation between the two molecular forms of alpha2-antiplasmin in blood', 'volume': '50', 'author': 'Kluft', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / The mutual relation between the two molecular forms of alpha2-antiplasmin in blood by Kluft (1983)10.1042/bj1630389
/ Biochem. J. / Kinetic properties of the primary inhibitor of plasmin from human plasma by Christensen (1977)10.1111/j.1432-1033.1978.tb12200.x
/ Eur. J. Biochem. / On the kinetics of the reaction between human antiplasmin and plasmin by Wiman (1978)10.1111/j.1432-1033.1978.tb12360.x
/ Eur. J. Biochem. / On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin by Wiman (1978){'key': '10.1016/S1040-8428(86)80014-2_bib272', 'series-title': 'The Physiological Inhibitors of Blood Coagulation and Fibrinolysis', 'first-page': '145', 'article-title': 'On the mechanism of the reaction between plasmin and alpha2-antiplasmin. Kinetics and structural changes', 'author': 'Wiman', 'year': '1979'}
/ The Physiological Inhibitors of Blood Coagulation and Fibrinolysis / On the mechanism of the reaction between plasmin and alpha2-antiplasmin. Kinetics and structural changes by Wiman (1979)10.1016/0014-5793(82)80230-5
/ FEBS Lett. / On the structure of the stable complex between plasmin and alpha2-antiplasmin by Nilsson (1982)10.1016/S0021-9258(19)85825-8
/ J. Biol. Chem. / Changes in antigenic structure and conformation of alpha2-antiplasmin induced by interaction with plasmin by Plow (1980)10.1016/0049-3848(74)90121-2
/ Thromb. Res. / Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitors by Collen (1974)10.1016/0049-3848(75)90140-1
/ Thromb. Res. / A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin alpha2-antiplasmin complexes in human plasma by Collen (1975){'key': '10.1016/S1040-8428(86)80014-2_bib277', 'first-page': '199', 'article-title': 'Immunochemical characterization of the plasmin-antiplasmin system. Basis for the specific detection of the plasmin-antiplasmin complex by latex agglutination assays', 'volume': '93', 'author': 'Plow', 'year': '1979', 'journal-title': 'J. Lab. Clin. Med.'}
/ J. Lab. Clin. Med. / Immunochemical characterization of the plasmin-antiplasmin system. Basis for the specific detection of the plasmin-antiplasmin complex by latex agglutination assays by Plow (1979)10.1111/j.1365-2362.1977.tb01565.x
/ Eur. J. Clin. Invest. / A latex agglutination test for rapid quantitative estimation of the plasmin-antiplasmin complex in human plasma by Collen (1977)10.3109/00365518309168219
/ Scand. J. Lab. Clin. Invest. / Determination of plasmin-alpha2-antiplasmin complex in plasma samples by means of a radioimmunoassay by Wiman (1983)10.1172/JCI110253
/ J. Clin. Invest. / Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay by Harpel (1981)10.3109/00365518009095590
/ Scand. J. Clin. Lab. Invest. / Binding of urokinase to plasma proteinase inhibitors by Holmberg (1980)10.1073/pnas.76.4.2013
/ Proc. Natl. Acad. Sci. U.S.A. / Inhibitory spectrum of alpha2-plasmin inhibitor by Salto (1979)10.1055/s-0038-1653443
/ Thromb. Haemost. / Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor by Korninger (1981)10.1016/0005-2744(77)90098-5
/ Biochim. Biophys. Acta / The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin by Edy (1977)10.3109/00365517709092640
/ Scand. J. Clin. Lab. Invest. / Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin by Oblsson (1977)10.1016/0049-3848(80)90302-3
/ Thromb. Res. / On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha2-antiplasmin by Wiman (1980)10.1093/oxfordjournals.jbchem.a131801
/ Biochem. J. / Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor by Moroi (1977)10.1016/0304-4165(77)90002-2
/ Biochim. Biophys. Acta / Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells by Collen (1977)10.1042/bj1330709
/ Biochem. J. / The interaction of alpha2-macroglobulin with protenases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism by Barret (1973){'key': '10.1016/S1040-8428(86)80014-2_bib290', 'series-title': 'Proteinase Inhibitors', 'first-page': '72', 'article-title': 'The unique nature of the interaction of alpha2-macroglobulin with proteinases', 'author': 'Barret', 'year': '1974'}
/ Proteinase Inhibitors / The unique nature of the interaction of alpha2-macroglobulin with proteinases by Barret (1974){'key': '10.1016/S1040-8428(86)80014-2_bib291', 'article-title': 'Protease inhibitors in plasma', 'volume': 'Vol. 1', 'author': 'Laurell', 'year': '1975'}
/ Protease inhibitors in plasma by Laurell (1975){'key': '10.1016/S1040-8428(86)80014-2_bib292', 'first-page': '639', 'article-title': 'Human alpha2-macroglobulin', 'volume': 'Vol. 45', 'author': 'Harpel', 'year': '1976'}
/ Human alpha2-macroglobulin by Harpel (1976)10.1084/jem.138.3.508
/ J. Exp. Med. / Studies on human plasma alpha2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure by Harpel (1973)10.1042/bj1390359
/ Biochem. J. / Interaction of alpha2-macroglobulin with proteinases by Werb (1974)10.1042/bj1810401
/ Biochem. J. / The electrophoretically “slow” and “fast” forms of alpha2-macroglobulin molecules by Barrett (1979)10.1042/bj1730027
/ Biochem. J. / Physical and chemical properties of human plasma alpha2-macroglobulin by Hall (1978)10.1016/S0021-9258(17)30030-3
/ J. Biol. Chem. / Structural characterization of human alpha2-macroglobulin subunits by Swenson (1979)10.1016/S0021-9258(17)34530-1
/ J. Biol. Chem. / Rotational relaxation of free and protease bound alpha2-macroglobulin by Pochon (1978)10.1016/0014-5793(80)80361-9
/ FEBS Lett. / A thiol-ester in alpha2-macroglobulin cleaved during proteinase complex formation by Sottrup-Jensen (1980)10.1016/0014-5793(81)80197-4
/ FEBS Lett. / Primary structure of the “bait” region for proteinases in alpha2-macroglobulin. Nature of the complex by Sottrup-Jensen (1981)10.1016/0014-5793(81)80039-7
/ FEBS Lett. / Sequence location of the reactive thiol-ester in human alpha2-macroglobulin by Sottrup-Jensen (1981)10.1042/bj2030405
/ Biochem. J. / Relation of internal thioesters to conformational change and receptor-recognition site in alpha2-macroglobulin by Van Leuven (1982)10.1016/0014-5793(82)80358-X
/ FEBS Lett. / Proteolysis at a lysine residue abolishes the receptor-recognition site of alpha2-macroglobulin complexes by Marijnen (1982)10.1016/0009-8981(67)90333-6
/ Clin. Chim. Acta / Serum alpha2-macroglobulin concentration and its variation with age and sex by Ganrot (1967)10.3109/00365517209080237
/ Scand. J. Clin. Lab. Invest. / A screening test for alpha1-antitrypsin deficiency by Laurell (1972)10.3109/00365517209080240
/ Scand. J. Clin. Lab. Invest. / Alpha2-macroglobulin, alpha1-antitrypsin and anti-thrombin III in plasma and serum during fibrinolytic therapy with urokinase by Arnesen (1972)10.1111/j.1600-0609.1979.tb02745.x
/ Scand. J. Haematol. / Hereditary alpha2-macroglobulin deficiency by Bergquist (1979){'key': '10.1016/S1040-8428(86)80014-2_bib308', 'series-title': 'Proteinase Inhibitors', 'first-page': '96', 'article-title': 'Interaction between endogenous proteases and plasma protease inhibitors in vitro and in vivo', 'author': 'Oblsson', 'year': '1974'}
/ Proteinase Inhibitors / Interaction between endogenous proteases and plasma protease inhibitors in vitro and in vivo by Oblsson (1974){'key': '10.1016/S1040-8428(86)80014-2_bib309', 'series-title': 'The Physiological Inhibitors of Blood Coagulation and Fibrinolysis', 'first-page': '239', 'article-title': 'Role of alpha2-macroglobulin as an inhibitor of coagulation', 'author': 'Abildgaard', 'year': '1979'}
/ The Physiological Inhibitors of Blood Coagulation and Fibrinolysis / Role of alpha2-macroglobulin as an inhibitor of coagulation by Abildgaard (1979)10.3109/00365516709093501
/ Scand. J. Clin. Lab. Invest. / Purification of two progressive antithrombins of human plasma by Abildgaard (1967){'key': '10.1016/S1040-8428(86)80014-2_bib311', 'series-title': 'Chemistry and Biology of Thrombin', 'first-page': '361', 'article-title': 'Thrombin inhibition in normal plasma', 'author': 'Shapiro', 'year': '1977'}
/ Chemistry and Biology of Thrombin / Thrombin inhibition in normal plasma by Shapiro (1977)10.1016/S0021-9258(18)32614-0
/ J. Biol. Chem. / The binding of human plasminogen to fibrin and fibrinogen by Adams Lucas (1983)10.1172/JCI111623
/ J. Clin. Invest. / Tissue-type plasminogen activator increases the binding of Glu-plasminogen to clots by Tran-Chang (1984){'key': '10.1016/S1040-8428(86)80014-2_bib314', 'first-page': '371', 'article-title': 'Adsorption to fibrin of native fragments of known primary structure from human plasminogen', 'volume': '668', 'author': 'Thersea', 'year': '1981', 'journal-title': 'Biochim. Biophys. Acta'}
/ Biochim. Biophys. Acta / Adsorption to fibrin of native fragments of known primary structure from human plasminogen by Thersea (1981)10.1016/0049-3848(77)90142-6
/ Thromb. Res. / Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor by Morol (1977)10.1016/0049-3848(80)90414-4
/ Thromb. Res. / Influence of alpha2-plasmin inhibitor on adsorption of plasminogen to fibrin by Aoki (1980)10.1042/bj1970619
/ Biochem. J. / Secondary site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin by Sueman (1981)10.1016/0049-3848(81)90115-8
/ Thromb. Res. / Histidine-rich glycoprotein in a normal and a clinical population by Lijsea (1981)10.1016/0049-3848(84)90079-3
/ Thromb. Res. / Histidine-rich glycoprotein and alpha2-plasmin inhibitor in inhibition of plasminogen binding to fibrin by Ichisese (1984)10.1172/JCI111578
/ J. Clin. Invest. / Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator by Silverstein (1984){'key': '10.1016/S1040-8428(86)80014-2_bib321', 'first-page': '14', 'article-title': 'Isolation and functional properties of the light chain of tissue-type plasminogen activator', 'volume': '14', 'author': 'Rijken', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Isolation and functional properties of the light chain of tissue-type plasminogen activator by Rijken (1984)10.1172/JCI110479
/ J. Clin. Invest. / Significance of cross-linking of alpha2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and hemostasis by Sakata (1982)10.1016/S0021-9258(18)33346-5
/ J. Biol. Chem. / Cross-linking of alpha2-plasmin inhibitor to fibrin catalyzed by activated fibrinstabilizing factor by Tamaki (1982)10.1016/0014-5793(83)80645-0
/ FEBS Lett. / Factor XIII-mediated cross-lining of NH2-terminal peptide of alpha2-plasmin inhibitor to fibrin by Ichinose (1983)10.1016/0049-3848(84)90081-1
/ Thromb. Res. / The molecular form of alpha2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII by Kluft (1984)10.1016/S0021-9258(17)33696-7
/ J. Biol. Chem. / Action of fibrin-stabilizing factor on cold-insoluble globulin and alpha2-macroglobulin in clotting plasma by Mosher (1976)10.1016/0014-5793(81)80198-6
/ FEBS Lett. / Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin by McDonagh (1981){'key': '10.1016/S1040-8428(86)80014-2_bib328', 'first-page': '18', 'article-title': 'Effect of fibronectin on the kinetics of plasminogen activation by the vascular plasminogen activator', 'volume': '14', 'author': 'Beckmann', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Effect of fibronectin on the kinetics of plasminogen activation by the vascular plasminogen activator by Beckmann (1984)10.1016/0049-3848(84)90067-7
/ Thromb. Res. / The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards by Brommer (1984)10.1016/0049-3848(84)90364-5
/ Thromb. Res. / Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro by Zamarron (1984)10.3109/00016346709158657
/ Acta Obstet. Gnyecol. Scand. / Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA). A double-bind investigation by Nilsson (1967)10.1152/jappl.1977.42.6.865
/ J. Appl. Physiol. / Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man by Collen (1977)10.1016/0049-3848(77)90192-X
/ Thromb. Res. / Plasmin-antiplasmin complex formation during defibrase infusion in man by Collen (1977)10.1172/JCI106927
/ J. Clin. Invest. / Metabolism of plasminogen in healthy subjects: effect of tranexamic acid by Collen (1972)10.1111/j.1365-2362.1978.tb00834.x
/ Eur. J. Clin. Invest. / Turnover of radiolabeled plasminogen and prothrombin in cirrhosis of the liver by Collen (1978){'key': '10.1016/S1040-8428(86)80014-2_bib336', 'first-page': '225', 'article-title': 'The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecological patients', 'volume': '151', 'author': 'Rakoczi', 'year': '1980', 'journal-title': 'Surg. Gynecol. Obstet.'}
/ Surg. Gynecol. Obstet. / The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecological patients by Rakoczi (1980)10.1001/archsurg.1973.01350200152032
/ Arch. Surg. / Relationship of the fibrinolytic system to postoperative thrombotic phenomena by Seutter (1973)10.1002/bjs.1800650413
/ Br. J. Surg. / Fibrinolytic activity in the vein wall after surgery by Aberg (1978)10.1016/S0140-6736(77)90302-6
/ Lancet / Fibrinolytic response to surgery, Labile and stable patterns and their relevance to postoperative deep vein thrombosis by Knight (1977)10.1002/bjs.1800630906
/ Br. J. Surg. / Plasma fibrinolysis and postoperative deep vein thrombosis by McIntyre (1976)10.1002/bjs.1800670121
/ Br. J. Surg. / Fibrinolysis and the prediction of postoperative deep vein thrombosis by Reilly (1980){'key': '10.1016/S1040-8428(86)80014-2_bib342', 'first-page': '313', 'article-title': 'Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis', 'volume': '138', 'author': 'Isacson', 'year': '1972', 'journal-title': 'Acta Chir. Scand.'}
/ Acta Chir. Scand. / Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis by Isacson (1972)10.1111/j.0954-6820.1975.tb19513.x
/ Acta Med. Scand. / Phenformin and ethyloestrenol in recurrent venous thrombosis by Nilsson (1975)10.1111/j.1600-0609.1982.tb00586.x
/ Scand. J. Haematol. / A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis by Jorgensae (1982)10.1055/s-0038-1661155
/ Thromb. Haemost. / Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis by Keraluger (1984)10.1136/bmj.2.6041.910
/ Br. Med. J. / Preoperative prediction of postoperative deep vein thrombosis by Claytea (1976)10.1016/S0140-6736(78)90181-2
/ Lancet / Prediction of postoperative leg vein thrombosis in gynaecological patients by Rakoczi (1978)10.1016/0049-3848(83)90059-2
/ Thromb. Res. / Fibrinolytic activity in plasma and deep vein thrombosis after major abdominal surgery by Mellbring (1983){'key': '10.1016/S1040-8428(86)80014-2_bib349', 'first-page': '59', 'article-title': 'Isolated plasminogen deficiency in a patient with recurrent thrombotic complications', 'volume': '50', 'author': 'ten Cate', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Isolated plasminogen deficiency in a patient with recurrent thrombotic complications by ten Cate (1983){'key': '10.1016/S1040-8428(86)80014-2_bib350', 'first-page': '22', 'article-title': 'Familial plasminogen deficiency in a patient with postoperative deep vein thrombosis', 'volume': '14', 'author': "D'Angelo", 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Familial plasminogen deficiency in a patient with postoperative deep vein thrombosis by D'Angelo (1984)10.1001/jama.237.17.1837
/ JAMA / Prevention of hyaline membrane disease with plasminogen. A cooperative study by Ambrus (1977)10.1172/JCI109034
/ J. Clin. Invest. / Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis by Aoki (1978)10.1016/0049-3848(83)90034-8
/ Thromb. Res. / Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis by Soria (1983)10.1016/S0021-9258(19)70806-0
/ J. Biol. Chem. / Molecular abnormality of plasminogen by Sakata (1980)10.1016/0049-3848(81)90154-7
/ Thromb. Res. / Abnormal plasminogen, a case of recurrent thrombosis by Kazama (1981)10.1016/S0021-9258(19)86809-6
/ J. Biol. Chem. / Physiological activation of the human plasminogen variants. Chicago I and Chicago II by Wohl (1979)10.1038/208143a0
/ Nature (London) / A new inherited coagulation disorder caused by an abnormal fibrinogen. Fibrinogen Baltimore by Beck (1983)10.1182/blood.V45.5.607.607
/ Blood / Fibrinogen New York, an abnormal fibrinogen associated with thromboembolism: functional evaluation by Mondhiry (1975)10.1007/BF00999857
/ Blut. / Fibrinogen Marburg. A new genetic variant of fibrinogen by Fuchs (1977)10.3109/00365518009095570
/ Scand. J. Clin. Lab. Invest. / Fibrinogen Copenhagen, an abnormal fibrinogen with defective polymerization and release of fibrinopeptide A but normal adsorption of plasminogen by Sandbjerg-Hansen (1980)10.1111/j.1365-2141.1983.tb07309.x
/ Br. J. Haematol. / A new type of congenital dysfibrinogenemia with defective fibrin lysis—Dusard syndrome: a possible relation to thrombosis by Soria (1983)10.1055/s-0038-1661033
/ Thromb. Haemost. / Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation by Lijnen (1984){'key': '10.1016/S1040-8428(86)80014-2_bib363', 'first-page': '100', 'article-title': 'Diurnal fluctuations in the activity in blood of the fast-acting t-PA inhibitor', 'volume': '14', 'author': 'Kluft', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Diurnal fluctuations in the activity in blood of the fast-acting t-PA inhibitor by Kluft (1984){'key': '10.1016/S1040-8428(86)80014-2_bib364', 'first-page': '26', 'article-title': 'Postoperative changes in the activity in blood of extrinsic (tissue-type) plasminogen activator and its fast-acting inhibitor', 'volume': '14', 'author': 'Kluft', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Postoperative changes in the activity in blood of extrinsic (tissue-type) plasminogen activator and its fast-acting inhibitor by Kluft (1984)10.1172/JCI111402
/ J. Clin. Invest. / Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation by Colucci (1984)10.1055/s-0038-1665299
/ Thromb. Haemost. / An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease by Bergsdorf (1983)10.1111/j.0954-6820.1978.tb14911.x
/ Acta Med. Scand. / A family with thromboembolic disease associated with deficient fibrinolytic, activity in vessel wall by Johansson (1978){'key': '10.1016/S1040-8428(86)80014-2_bib368', 'first-page': '24', 'article-title': 'A family with thrombosis associated with high level of tissue plasminogen activator inhibitor', 'volume': '14', 'author': 'Nilsson', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / A family with thrombosis associated with high level of tissue plasminogen activator inhibitor by Nilsson (1984){'key': '10.1016/S1040-8428(86)80014-2_bib369', 'first-page': '38', 'article-title': 'Studies on the fast-acting inhibitor of tissue-type plasminogen activator and urokinase in human plasma', 'volume': '14', 'author': 'Kruithof', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Studies on the fast-acting inhibitor of tissue-type plasminogen activator and urokinase in human plasma by Kruithof (1984)10.1055/s-0038-1661161
/ Thromb. Haemost. / Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma by Brommer (1984){'key': '10.1016/S1040-8428(86)80014-2_bib371', 'first-page': '101', 'article-title': 'An inhibitor of t-PA in pregnant plasma', 'volume': '14', 'author': 'stedt', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / An inhibitor of t-PA in pregnant plasma by stedt (1984)10.1055/s-0038-1661154
/ Thromb. Haemost. / The fast inhibitor of tissue plasminogen activator in plasma during pregnancy by Wilman (1984)10.1055/s-0038-1661030
/ Thromb. Haemost. / A sequential study of plasma histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis by Jespersen (1984){'key': '10.1016/S1040-8428(86)80014-2_bib374', 'first-page': '370', 'article-title': 'Immunochemical determination of histidinerich glycoprotein in healthy subjects and in a clinical population', 'volume': 'Vol. 6', 'author': 'Castel', 'year': '1983'}
/ Immunochemical determination of histidinerich glycoprotein in healthy subjects and in a clinical population by Castel (1983)10.1055/s-0038-1657281
/ Thromb. Haemost. / Decreased levels of histidine-rich glycoprotein (HRG) and incresed levels of free plasminogen in women on oral contraceptives low in estrogen by Jespersen (1982){'key': '10.1016/S1040-8428(86)80014-2_bib376', 'first-page': '281', 'article-title': 'Changes in the primary fibrinolysis inhibitor (alpha2-antiplasmin) after cardio-pulmonary bypass', 'volume': '45', 'author': 'Bagge', 'year': '1981', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Changes in the primary fibrinolysis inhibitor (alpha2-antiplasmin) after cardio-pulmonary bypass by Bagge (1981){'key': '10.1016/S1040-8428(86)80014-2_bib377', 'first-page': '27', 'article-title': 'Variation of the plasminogen-binding and the non-plasminogen-binding forms of alpha2-antiplasmin after a standardized trauma', 'volume': '14', 'author': 'Jacobsson', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Variation of the plasminogen-binding and the non-plasminogen-binding forms of alpha2-antiplasmin after a standardized trauma by Jacobsson (1984)10.1016/S0021-9258(17)43245-5
/ J. Biol. Chem. / Plasminogen activation in diabetes mellitus. Kinetic analysis of plasmin formation using components isolated from the plasma of diabetic donors by Geiger (1984)10.1172/JCI108784
/ J. Clin. Invest. / The behaviour of alpha2-plasmin inhibitor in fibrinolytic states by Aoki (1977)10.1084/jem.146.4.1033
/ J. Exp. Med. / Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin by Harpel (1977)10.1055/s-0038-1646120
/ Thromb. Haemost. / Effects of alpha2-plamin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin by Aoki (1978)10.1016/0049-3848(80)90187-5
/ Thromb. Res. / Interaction of plasmin with alpha2-macroglobulin and alpha2-antiplasmin in the presence and absence of tranexamic acid by Takada (1980)10.1055/s-0038-1650002
/ Thromb. Haemost. / Interaction of plasmin with tranexamic acid and alpha2-plasmin inhibitor in the plasma and clot by Takada (1980)10.1055/s-0038-1646655
/ Thromb. Haemost. / Biochemical changes noted during intermittent administration of streptokinase by Verstraete (1978)10.1016/0049-3848(79)90118-X
/ Thromb. Res. / Alpha2-antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy by Collen (1979){'key': '10.1016/S1040-8428(86)80014-2_bib386', 'first-page': '155', 'article-title': 'Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis', 'volume': '7', 'author': 'Teger-Nilsson', 'year': '1978', 'journal-title': 'Haemostasis'}
/ Haemostasis / Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis by Teger-Nilsson (1978){'key': '10.1016/S1040-8428(86)80014-2_bib387', 'series-title': 'Synthetic Substrates in Clinical Blood Coagulation Assay', 'first-page': '93', 'article-title': 'Alpha2-antiplasmin assay: amidolytic and immunological method', 'author': 'Samama', 'year': '1980'}
/ Synthetic Substrates in Clinical Blood Coagulation Assay / Alpha2-antiplasmin assay: amidolytic and immunological method by Samama (1980)10.1016/0049-3848(80)90088-2
/ Thromb. Res. / Alpha2-plasmin inhibitor is among acute phase reactants by Matsuda (1980)10.1136/bmj.1.6171.1122-a
/ Br. Med. J. / Antiplasmin concentrations after surgery: failure of alpha2-antiplasmin to rise in patients with venous thrombosis by Taberner (1979)10.1159/000128061
/ Eur. Surg. Res. / Changes in antiplasmin and plasmin activities during extreme hemodilutin and open heart surgery in dogs by Assen (1979)10.1055/s-0038-1652893
/ Thromb. Haemost. / Intra-operative antithrombin III, plasminogen and alpha2-antiplasmin behaviour by Buller (1981)10.1016/0049-3848(80)90042-0
/ Thromb. Res. / Decreased alpha2-antiplasmin levels in patients suffering from obstructive peripheral arterial disease by Frisch (1980)10.1016/0026-2862(76)90054-6
/ Microvasc. Res. / The microembolism syndrome by Saldeen (1976)10.1055/s-0038-1652838
/ Thromb. Haemost. / Delayed elimination of fibrin from the lungs in rats treated with the primary fibrinolysis inhibitor alpha2-antiplasmin by Carlin (1981){'key': '10.1016/S1040-8428(86)80014-2_bib395', 'first-page': '164', 'article-title': 'Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs', 'volume': '7', 'author': 'Aasen', 'year': '1978', 'journal-title': 'Haemostasis'}
/ Haemostasis / Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs by Aasen (1978)10.1016/0049-3848(80)90214-5
/ Thromb. Res. / Plasminogen concentrations and functional activities and concentrations of plasmin inhibitors in plasma samples from normal subjects and patients with septic shock by Gallimore (1980)10.1016/0049-3848(79)90086-0
/ Thromb. Res. / Role of alpha2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage by Hayashi (1979){'key': '10.1016/S1040-8428(86)80014-2_bib398', 'first-page': '51', 'article-title': 'Plasmin inhibitors in different fibrinolytic treatment pattens', 'volume': '10', 'author': 'Lasberra', 'year': '1981', 'journal-title': 'Haemostasis'}
/ Haemostasis / Plasmin inhibitors in different fibrinolytic treatment pattens by Lasberra (1981){'issue': 'Suppl.', 'key': '10.1016/S1040-8428(86)80014-2_bib399', 'first-page': '1', 'article-title': 'On coagulation and fibrinolysis in renal failure', 'volume': '15', 'author': 'Larssen', 'year': '1971', 'journal-title': 'Scand. J. Haematol.'}
/ Scand. J. Haematol. / On coagulation and fibrinolysis in renal failure by Larssen (1971)10.1055/s-0038-1653178
/ Thromb. Haemost. / Acquired alpha2-antiplasmin deficiency in patients with glomerular proteinuria by Tabermer (1981)10.1055/s-0038-1648103
/ Thromb. Diath. Haemorrh. / Decreased fibrinolysis in Bechçet's disease by Chajek (1973){'key': '10.1016/S1040-8428(86)80014-2_bib402', 'first-page': '303', 'article-title': "Inhibition of the fibrinolytic system in Hechçet's disease", 'volume': '6', 'author': 'Asbeck', 'year': '1977', 'journal-title': 'Haemostasis'}
/ Haemostasis / Inhibition of the fibrinolytic system in Hechçet's disease by Asbeck (1977)10.1002/ajh.2830070307
/ Am. J. Hematol. / Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn by Ambrus (1979)10.3109/00365517309082418
/ Scand. J. Clin. Lab. Invest. / The inhibition of tissue plasmirogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects by Thorsen (1973){'key': '10.1016/S1040-8428(86)80014-2_bib405', 'first-page': '218', 'article-title': 'Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma', 'volume': '5', 'author': 'Chemmensen', 'year': '1976', 'journal-title': 'Haemostusis'}
/ Haemostusis / Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma by Chemmensen (1976){'key': '10.1016/S1040-8428(86)80014-2_bib406', 'first-page': '1334', 'article-title': 'Alpha2-plasmin inhibitor deficiency (Miyasato disease)', 'volume': 'ii', 'author': 'Kole', 'year': '1978', 'journal-title': 'Lancet'}
/ Lancet / Alpha2-plasmin inhibitor deficiency (Miyasato disease) by Kole (1978)10.1016/S0140-6736(79)91481-8
/ Lancet / Hamozygous alpha2-antiplasmin deficiency by Kluft (1979)10.1182/blood.V59.6.1246.1246
/ Blood / A bleeding disorder due to deficiency of alpha2-antiplasmin by Miles (1982)10.1172/JCI109387
/ J. Clin. Invest. / Congenital deficiency of alpha2-plasmin inhibitor associated with severe hemorrhagic tendency by Aoki (1979)10.1016/S0140-6736(79)90744-X
/ Lancet / Alpha2-plasmin inhibitor deficiency by Lipinski (1979)10.1016/S0140-6736(79)92800-9
/ Lancet / Alpha2-antiplasmin inhibitor deficiency by Collen (1979)10.1182/blood.V55.3.483.483
/ Blood / Fibrinolytic states in a patient with congenital deficiency of alpha2-plasmin inhibitor by Aoki (1980)10.1016/0049-3848(83)90462-0
/ Thromb. Res. / Hereditary alpha2-antiplasmin deficiency by Stormorken (1983){'key': '10.1016/S1040-8428(86)80014-2_bib414', 'first-page': '176', 'article-title': 'Congenital deficiency of alpha2-plasmin inhibitor in three sisters', 'volume': '11', 'author': 'Yoshioka', 'year': '1982', 'journal-title': 'Haemostasis'}
/ Haemostasis / Congenital deficiency of alpha2-plasmin inhibitor in three sisters by Yoshioka (1982)10.1182/blood.V59.6.1169.1169
/ Blood / A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha2-antiplasmin by Kluft (1982){'key': '10.1016/S1040-8428(86)80014-2_bib416', 'first-page': '170', 'article-title': 'Alpha2-antiplasmin Enschede: an autosomal recessive hemorrhagic disorder caused by a disfunctional alpha2-antiplasmin molecule', 'volume': '50', 'author': 'Nieuwenbuis', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / Alpha2-antiplasmin Enschede: an autosomal recessive hemorrhagic disorder caused by a disfunctional alpha2-antiplasmin molecule by Nieuwenbuis (1983)10.1016/0009-8981(78)90481-3
/ Clin. Chim. Acta / The alpha2-plasmin inhibitor levels in liver diseases by Aoki (1978)10.1016/0002-9343(82)90175-9
/ Am. J. Med. / Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis by Saito (1982)10.1016/0049-3848(80)90331-X
/ Thromb. Res. / Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat by Hogstorp (1980)10.1182/blood.V61.2.267.267
/ Blood / A new life-long hemorrhagic disorder due to excess plasminogen activator by Booth (1983)10.1055/s-0038-1661171
/ Thromb. Haemost. / Inhcrited fibrinolytic disorder due to an enhanced plasminogen activator level by Aznar (1984)10.1016/0002-8703(82)90267-8
/ Am. Heart J. / High-dose, brief intravenous streptokinase early in acute myocardial infarction by Spann (1982)10.1161/01.CIR.67.3.536
/ Circulation / Intravenous short-term infusion of streptokinase in acute myocardial infarction by Schroeder (1983){'key': '10.1016/S1040-8428(86)80014-2_bib424', 'series-title': 'Fibrinolytics and Antifibrinolytics', 'first-page': '209', 'article-title': 'Urokinase', 'author': 'Duckert', 'year': '1978'}
/ Fibrinolytics and Antifibrinolytics / Urokinase by Duckert (1978)10.1016/S0140-6736(75)90774-6
/ Lancet / Treament of deep-vein thrombosis with intermittent streptokinase and plasminogen infusion by Kakkar (1975){'key': '10.1016/S1040-8428(86)80014-2_bib426', 'first-page': '513', 'article-title': 'Intérêt du traitement séquentiel lysyl-plasminogène-urokinase et thérapeutique thrombolytique', 'volume': '16', 'author': 'Brochier', 'year': '1977', 'journal-title': 'Coeur Méd. Interne'}
/ Coeur Méd. Interne / Intérêt du traitement séquentiel lysyl-plasminogène-urokinase et thérapeutique thrombolytique by Brochier (1977)10.1055/s-0038-1657254
/ Thromb. Haemost. / Sequential treatment of deep leg vein thrombosis with procine plasmin and low dose streptokinase by Marbet (1982){'key': '10.1016/S1040-8428(86)80014-2_bib428', 'first-page': '181', 'article-title': 'A combined treatment with Defibrase and streptokinase', 'volume': '26', 'author': 'Latallo', 'year': '1975', 'journal-title': 'Akt. Probl. Angiol.'}
/ Akt. Probl. Angiol. / A combined treatment with Defibrase and streptokinase by Latallo (1975){'key': '10.1016/S1040-8428(86)80014-2_bib429', 'first-page': '188', 'article-title': 'Niedrig dosierte thrombolytische Therapie zor Wiedetherstellung der Strombahn bei arteriellen Verschlüssen', 'volume': '105', 'author': 'Hees', 'year': '1980', 'journal-title': 'Dtsch. Med. Wochenschr.'}
/ Dtsch. Med. Wochenschr. / Niedrig dosierte thrombolytische Therapie zor Wiedetherstellung der Strombahn bei arteriellen Verschlüssen by Hees (1980)10.1016/0049-3848(78)90005-1
/ Thromb. Res. / Effects of the synthetic fibrinolytic agents ortho-thymotic acid and S-1623 on the reaction between human plasmin and antiplasmin by Prandini (1978)10.1016/0049-3848(78)90258-X
/ Thromb. Res. / Influence of dextran 70 on the action of the primary fibrinolysis inhibitor (“alpha2-plasmin inhibitor”) by Carlin (1978)10.1016/0049-3848(80)90408-9
/ Thromb. Res. / On the interaction between dextran and the primary fibrinolysis inhibitor alpha2-antiplasmin by Carlia (1980)10.1016/0049-3848(80)90037-7
/ Thromb. Res. / Mechanism for the inhibitor, effect of dextran on alpha2-plasmin inhibitor activity by Katsuda (1980)10.1055/s-0038-1661049
/ Thromb. Haemost. / Stanazolol-induced changes in fibrinolysis and coagulation in healthy adults by Kluft (1984){'key': '10.1016/S1040-8428(86)80014-2_bib435', 'first-page': '33', 'article-title': 'Danazol—effects on fibrinolysis', 'volume': '14', 'author': 'Hambley', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Danazol—effects on fibrinolysis by Hambley (1984){'key': '10.1016/S1040-8428(86)80014-2_bib436', 'first-page': '37', 'article-title': 'Defibrotide, a fibrinclysis stimulating agent with antithrombotic activity', 'volume': '14', 'author': 'Coccheri', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Defibrotide, a fibrinclysis stimulating agent with antithrombotic activity by Coccheri (1984){'key': '10.1016/S1040-8428(86)80014-2_bib437', 'first-page': '36', 'article-title': 'The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. A proposal for the mode of action', 'volume': '14', 'author': 'Marsh', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. A proposal for the mode of action by Marsh (1984){'key': '10.1016/S1040-8428(86)80014-2_bib438', 'first-page': '544', 'article-title': 'Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2, and I2', 'volume': '222', 'author': 'Crutchley', 'year': '1982', 'journal-title': 'J. Pharm. Exp. Ther.'}
/ J. Pharm. Exp. Ther. / Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2, and I2 by Crutchley (1982)10.1055/s-0038-1661110
/ Thromb. Haemost. / Modulation of rapid plasminogen activator inhibitor in plasma by Stanazolol by Verheijen (1984)10.1038/290505a0
/ Nature (London) / Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy by Smith (1981)10.1055/s-0038-1661069
/ Thromb. Haemost. / Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism by Dupe (1984)10.1016/0049-3848(81)90008-6
/ Thromb. Res. / On the fibrinolytic and thrombolytic properties of activesite p-anisoylated streptokinase-plasminogen complex (BRL 26921) by Matsuo (1981)10.1055/s-0038-1661059
/ Thromb. Haemost. / Acylated streptokinase-plasminogen complex in patients with acute myocardial infarction by Walker (1984){'key': '10.1016/S1040-8428(86)80014-2_bib444', 'first-page': '274', 'article-title': 'Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay', 'volume': '101', 'author': 'Rijken', 'year': '1983', 'journal-title': 'J. Lab. Clin. Med.'}
/ J. Lab. Clin. Med. / Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay by Rijken (1983)10.1016/0049-3848(83)90410-3
/ Thromb. Res. / Tissue plasminogen activator in human plasma measured by radioimmunoassay by MacGregor (1983){'key': '10.1016/S1040-8428(86)80014-2_bib446', 'first-page': '269', 'article-title': 'An enzyme immunoassay for human tissue-type plasminogen activator', 'volume': '50', 'author': 'Rijken', 'year': '1983', 'journal-title': 'Thromb. Haemost.'}
/ Thromb. Haemost. / An enzyme immunoassay for human tissue-type plasminogen activator by Rijken (1983)10.1016/0049-3848(84)90175-0
/ Thromb. Res. / Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay by Rijken (1984)10.1016/0003-2697(83)90730-3
/ Anal. Biochem. / Determination of tissue plasminogen activator by an enzyme-immunoassay by Matsuo (1983)10.1016/0003-9861(52)90121-5
/ Arch. Biochem. Biophys. / Fibrin plate method for estimating fibrinolytic activity by Astrup (1952)10.1055/s-0038-1665244
/ Thromb. Haemost. / Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood by Kluft (1983)10.1016/S0300-9084(79)80202-3
/ Biochimie / Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. Role of serum studied by a new spectrophotometric assay for plasminogen activators by Drapler (1979)10.1055/s-0038-1657277
/ Thromb. Haemost. / A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma by Verheijen (1982)10.1016/S0009-8981(83)80012-6
/ Clin. Chim. Acta / Plasminogen activator release during venous statis and exercise as determined by a new specific assay by Wiman (1983)10.1016/0049-3848(84)90286-X
/ Thromb. Res. / A sersitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-Sepharose by Gyzander (1984)10.1055/s-0038-1650175
/ Thromb. Haemost. / Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro by Matsuo (1981)10.1016/0049-3848(81)90254-1
/ Thromb. Res. / Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system by Mattson (1981)10.1055/s-0038-1653411
/ Thromb. Haemost. / Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro by Korninger (1981)10.1055/s-0038-1661202
/ Thromb. Haemost. / In vitro fibrinolytic activity of recombinant tissuetype plasminogen activator in the plasma of various primate species by Lijnen (1984)10.1038/291590a0
/ Nature (London) / Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolism by Matsuo (1981)10.1172/JCI110483
/ J. Clin. Invest. / Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis by Korninger (1982){'key': '10.1016/S1040-8428(86)80014-2_bib461', 'first-page': '463', 'article-title': 'Studies of the thrombolytic action of a tissue plasminogen activator in dogs', 'volume': 'Vol. 6', 'author': 'Sampol', 'year': '1983'}
/ Studies of the thrombolytic action of a tissue plasminogen activator in dogs by Sampol (1983){'key': '10.1016/S1040-8428(86)80014-2_bib462', 'first-page': '471', 'article-title': 'Tissue plasminogen activator effectively lyses intravascular fibrin deposits in the rat lung', 'volume': 'Vol. 6', 'author': 'Carlin', 'year': '1983'}
/ Tissue plasminogen activator effectively lyses intravascular fibrin deposits in the rat lung by Carlin (1983)10.1172/JCI110778
/ J. Clin. Invest. / Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration by Collen (1983)10.1126/science.6602378
/ Science / Clot-selective coronary thrombolysis with tissue-type plasminogen activator by Bergmann (1983)10.1161/01.CIR.69.3.605
/ Circulation / Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology by Van de Werf (1984)10.1161/01.CIR.70.4.700
/ Circulation / Coronary thrombolysis with recombinant human tissue plasminogen activator by Gold (1984)10.1172/JCI111701
/ J. Clin. Invest. / Coronary thrombolysis and infarct size reduction following intravenous infusion of recombinant tissue-type plasminogen activator in non-human primates by Flameng (1985)- Agnelli, G., Buchanan, M. R., Fernandez, F. Boneu, B., Van Rijn, J., Hirsh., J., and Colken, D., Hemorrhage-free thrombolysis by tissue plasminogen activator in rabbits: a comparison with streptokinase, Circulation, in press.
{'key': '10.1016/S1040-8428(86)80014-2_bib469', 'first-page': '1018', 'article-title': 'Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator', 'volume': 'ii', 'author': 'Welmar', 'year': '1981', 'journal-title': 'Lancet'}
/ Lancet / Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator by Welmar (1981)- Verstraete, M. and Collen, D., Thrombolytic properties of, tissue-type plasminogen activator in experimental venous thrombosis, in Biological and Therapeutic Properties of New Thrombolytic Agents, Collen, D., Lijnen, H. R., and Verstraete, M., Eds., Churchill Livingstone, Edinburgh, in press.
10.1056/NEJM198403083101001
/ N. Engl. J. Med. / Clot selective coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction by Van de Werf (1984)10.1161/01.CIR.70.6.1012
/ Circulation / Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective., randomized, placebo-controlled trial by Collen (1984){'key': '10.1016/S1040-8428(86)80014-2_bib473', 'first-page': '15', 'article-title': 'Comparison of pro-UK and t-PA in vitro clotlysis', 'volume': '14', 'author': 'Pannell', 'year': '1984', 'journal-title': 'Haemostasis'}
/ Haemostasis / Comparison of pro-UK and t-PA in vitro clotlysis by Pannell (1984)10.1055/s-0038-1661130
/ Thromb. Haemost. / Biological and thrombolytic properties of proenzyme and active forms of human urokinase. IV. Variability in fibrinolytic response of plasma of several mammalian species by Lijnen (1984)10.7326/0003-4819-103-1-64
/ Ann. Int. Med. / Thrombolytic treatment with recombinant tissue-type plasminogen, activator (rt-PA) in a patient with massive pulmonary embolism by Bounameaux (1985)
Dates
Type | When |
---|---|
Created | 18 years, 1 month ago (July 18, 2007, 7:45 a.m.) |
Deposited | 2 years, 3 months ago (May 13, 2023, 8:12 a.m.) |
Indexed | 3 months, 1 week ago (May 23, 2025, 6:30 a.m.) |
Issued | 39 years, 8 months ago (Jan. 1, 1986) |
Published | 39 years, 8 months ago (Jan. 1, 1986) |
Published Print | 39 years, 8 months ago (Jan. 1, 1986) |
@article{Collen_1986, title={The fibrinolytic system in man}, volume={4}, ISSN={1040-8428}, url={http://dx.doi.org/10.1016/s1040-8428(86)80014-2}, DOI={10.1016/s1040-8428(86)80014-2}, number={3}, journal={Critical Reviews in Oncology/Hematology}, publisher={Elsevier BV}, author={Collen, D. and Lijnen, H.R. and Plow, Edward F.}, year={1986}, month=jan, pages={249–301} }